Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
NCT06299683 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2026-01-21
Summary
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a severe pain condition affecting 3-8 million people in the United States lacking treatments that work. Emotional suffering is common in IC/BPS and known to make physical symptoms worse, and studies show patient sub-groups respond differently to treatment. Individuals with IC/BPS have distinct subgroups, or "phenotypes," largely characterized by the distribution of pain throughout the body. Supported by our preliminary evidence, the overall goal of this project is to assess how IC/BPS phenotype may affect response to two different therapies often given without regard to patient phenotype, pelvic floor physical therapy (PT) and cognitive-behavioral therapy (CBT) for IC/BPS.
Conditions
- Chronic Interstitial Cystitis
- Bladder Pain Syndrome
- Painful Bladder Syndrome
- Cystitis, Interstitial
- Cystitis, Chronic Interstitial
- Interstitial Cystitis
- Interstitial Cystitis, Chronic
- Interstitial Cystitis (Chronic) With Hematuria
- Interstitial Cystitis (Chronic) Without Hematuria
- Chronic Prostatitis
- Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions
- BEHAVIORAL
-
Psychosocial Treatment
The psychosocial self-management intervention consists of 8 weekly 50-minute individual visits with an assigned trained therapist. Sessions follow a structured protocol that has been developed with the patient population and tested in a prior study. Treatment modules are individualized and include topics such as pain coping strategies, relaxation training, education on IC/BPS, and communication strategies.
- OTHER
-
Pelvic Floor Physical Therapy
The pelvic floor physical therapy condition consists of 10 weekly 45-minute individual visits with an assigned trained physical therapist. In IC/BPS, pelvic floor physical therapy (PT) uses manual manipulation to release localized muscle tension, trigger points, and correct other scars and restrictions to reduce pain and urgency symptoms. Specific techniques will include external connective tissue manipulation to the abdominal wall, back, buttocks and thighs, myofascial trigger point release, and internal transvaginal/transrectal treatment of the soft tissues of the pelvic floor with connective tissue and myofascial manipulation to pelvic floor musculature
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Lindsey McKernan, PhD, MPH · Vanderbilt University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-01
- Primary Completion
- 2027-04-05
- Completion
- 2028-04-04
Countries
- United States
Study Locations
More Related Trials
-
Hypnosis for Bladder Pain Syndrome
NCT04010513 ·Status: COMPLETED ·Phase: NA
-
Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome
NCT02457182 ·Status: COMPLETED ·Phase: NA
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
NCT04734847 ·Status: RECRUITING ·Phase: NA
-
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
NCT06096597 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome
NCT06209008 ·Status: COMPLETED ·Phase: PHASE3
-
Acupuncture First for IC/BPS
NCT06366269 ·Status: RECRUITING ·Phase: NA
-
The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients
NCT03722992 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis
NCT02787083 ·Status: TERMINATED ·Phase: PHASE3
-
Microbiomes of Pelvic Pain
NCT01738464 ·Status: COMPLETED
-
An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis
NCT00739739 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.
NCT00775281 ·Status: COMPLETED
-
Diagnostic Challenges in IC (and Male CPPS)
NCT00672087 ·Status: COMPLETED
-
Biopsychosocial and Conventional Approach in Bladder Pain Syndrome
NCT05155384 ·Status: UNKNOWN ·Phase: NA
-
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
NCT01098279 ·Status: COMPLETED
-
Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide
NCT05260112 ·Status: COMPLETED ·Phase: NA
-
Linkage Analysis in Interstitial Cystitis
NCT00675298 ·Status: COMPLETED
-
Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome
NCT06285214 ·Status: COMPLETED ·Phase: PHASE1
-
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
NCT01731470 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome
NCT04789135 ·Status: UNKNOWN ·Phase: PHASE2
-
Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
NCT01990898 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis
NCT01138800 ·Status: COMPLETED
-
Auricular Acupressure Therapy for Patients With IC/BPS
NCT05857020 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
NCT00919113 ·Status: COMPLETED ·Phase: PHASE2
-
Identifying Genetic Causes of IC/BPS
NCT00389142 ·Status: RECRUITING
-
Investigation of the Effectiveness of Acupuncture in Patients Diagnosed With Interstitial Cystitis
NCT06232200 ·Status: COMPLETED ·Phase: NA